NEW YORK, March 24, 2026 — BioAffinity Technologies (NASDAQ: BIAF) is extending one of the most aggressive small-cap premarket runs of the session, adding approximately 20% to 40% in early Tuesday trading after surging 85% on Monday to break above its 200-day moving average for the first time since April 2025. The move places BIAF […]